ARTICLE | Management Tracks
Legault named Egle chairman
Plus Tom Hughes becomes chairman of Totus, and updates from Immunicum, Kbio and more
May 5, 2022 11:36 PM UTC
Paris-based oncology and autoimmune disease company Egle Therapeutics S.A.S. appointed Pierre Legault chairman. Legault was director of Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) and chairman of Artios Pharma Ltd., Bicycle Therapeutics plc (NASDAQ:BCYC) and Sityrx Therapeutics. Egle is developing therapies targeting suppressor regulatory T cells; it raised a €40 million series A co-led by LSP and Bpifrance in October.
Totus Medicines Inc. appointed Tom Hughes as chairman. He is president and CEO of Navitor Pharmaceuticals Inc. and was CEO of Zafgen Inc. Totus plans to discover and develop therapies against “undruggable” targets; it raised a $40 million series A round led by DCVC Bio and Northpond Ventures in December. ...